Expression of CD94/NKG2C is unrelated to HSV or EBV serology
Serologic status* . | No. . | % CD94/NKG2C+† . | P‡ . |
---|---|---|---|
HCMV | |||
Negative | 34 | 0.3 ± 0.4 | < .001 |
0.2 (0.1-1.7) | |||
Positive | 34 | 3.5 ± 4.4 | |
2.2 (0.1-22.3) | |||
HSV | |||
Negative | 8 | 3.0 ± 4.8 | .39 |
0.6 (0.1-11) | |||
Positive | 23 | 1.5 ± 2.1 | |
0.3 (0.1-6.5) | |||
EBV | |||
Negative | 6 | 3.4 ± 4.1 | .21 |
1.9 (0.1-10.4) | |||
Positive | 25 | 1.5 ± 2.6 | |
0.2 (0.1-11) |
Serologic status* . | No. . | % CD94/NKG2C+† . | P‡ . |
---|---|---|---|
HCMV | |||
Negative | 34 | 0.3 ± 0.4 | < .001 |
0.2 (0.1-1.7) | |||
Positive | 34 | 3.5 ± 4.4 | |
2.2 (0.1-22.3) | |||
HSV | |||
Negative | 8 | 3.0 ± 4.8 | .39 |
0.6 (0.1-11) | |||
Positive | 23 | 1.5 ± 2.1 | |
0.3 (0.1-6.5) | |||
EBV | |||
Negative | 6 | 3.4 ± 4.1 | .21 |
1.9 (0.1-10.4) | |||
Positive | 25 | 1.5 ± 2.6 | |
0.2 (0.1-11) |